Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |